84 related articles for article (PubMed ID: 28041846)
21. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
[TBL] [Abstract][Full Text] [Related]
22. Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course.
Bagnara D; Tang C; Brown JR; Kasar S; Fernandes S; Colombo M; Vergani S; Mazzarello AN; Ghiotto F; Bruno S; Morabito F; Rai KR; Kolitz JE; Barrientos JC; Allen SL; Fais F; Scharff MD; MacCarthy T; Chiorazzi N
Front Oncol; 2021; 11():640731. PubMed ID: 34113563
[TBL] [Abstract][Full Text] [Related]
23. Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.
Abruzzo LV; Barron LL; Anderson K; Newman RJ; Wierda WG; O'brien S; Ferrajoli A; Luthra M; Talwalkar S; Luthra R; Jones D; Keating MJ; Coombes KR
J Mol Diagn; 2007 Sep; 9(4):546-55. PubMed ID: 17690214
[TBL] [Abstract][Full Text] [Related]
25. Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Knisbacher BA; Lin Z; Hahn CK; Nadeu F; Duran-Ferrer M; Stevenson KE; Tausch E; Delgado J; Barbera-Mourelle A; Taylor-Weiner A; Bousquets-Muñoz P; Diaz-Navarro A; Dunford A; Anand S; Kretzmer H; Gutierrez-Abril J; López-Tamargo S; Fernandes SM; Sun C; Sivina M; Rassenti LZ; Schneider C; Li S; Parida L; Meissner A; Aguet F; Burger JA; Wiestner A; Kipps TJ; Brown JR; Hallek M; Stewart C; Neuberg DS; Martín-Subero JI; Puente XS; Stilgenbauer S; Wu CJ; Campo E; Getz G
Nat Genet; 2022 Nov; 54(11):1664-1674. PubMed ID: 35927489
[TBL] [Abstract][Full Text] [Related]
26. Computational Inference, Validation, and Analysis of 5'UTR-Leader Sequences of Alleles of Immunoglobulin Heavy Chain Variable Genes.
Huang Y; Thörnqvist L; Ohlin M
Front Immunol; 2021; 12():730105. PubMed ID: 34671351
[TBL] [Abstract][Full Text] [Related]
27. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia.
Kaufman M; Yan XJ; Li W; Ghia EM; Langerak AW; Rassenti LZ; Belessi C; Kay NE; Davi F; Byrd JC; Pospisilova S; Brown JR; Catherwood M; Davis Z; Oscier D; Montillo M; Trentin L; Rosenquist R; Ghia P; Barrientos JC; Kolitz JE; Allen SL; Rai KR; Stamatopoulos K; Kipps TJ; Neuberg D; Chiorazzi N
Front Oncol; 2022; 12():897280. PubMed ID: 35903706
[TBL] [Abstract][Full Text] [Related]
28. Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia.
Parvin S; Aryal A; Yin S; Fell GG; Davids MS; Wu CJ; Letai A
Blood Adv; 2023 Oct; 7(19):5877-5889. PubMed ID: 37428863
[TBL] [Abstract][Full Text] [Related]
29. ImmunoTyper-SR: A computational approach for genotyping immunoglobulin heavy chain variable genes using short-read data.
Ford MKB; Hari A; Rodriguez O; Xu J; Lack J; Oguz C; Zhang Y; Weber S; Magliocco M; Barnett J; Xirasagar S; Samuel S; Imberti L; Bonfanti P; Biondi A; Dalgard CL; Chanock S; Rosen L; Holland S; Su H; Notarangelo L; ; Vishkin U; Watson CT; Sahinalp SC
Cell Syst; 2022 Oct; 13(10):808-816.e5. PubMed ID: 36265467
[TBL] [Abstract][Full Text] [Related]
30. Estimating Copy Number and Allelic Variation at the Immunoglobulin Heavy Chain Locus Using Short Reads.
Luo S; Yu JA; Song YS
PLoS Comput Biol; 2016 Sep; 12(9):e1005117. PubMed ID: 27632220
[TBL] [Abstract][Full Text] [Related]
31. Chronic lymphocytic leukaemia.
Kipps TJ; Stevenson FK; Wu CJ; Croce CM; Packham G; Wierda WG; O'Brien S; Gribben J; Rai K
Nat Rev Dis Primers; 2017 Jan; 3():16096. PubMed ID: 28102226
[TBL] [Abstract][Full Text] [Related]
32. ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
Wiggers TG; Westra G; Westers TM; Abbes AP; Strunk A; Kuiper-Kramer E; Poddighe P; van de Loosdrecht AA; Chamuleau ME
Cytometry B Clin Cytom; 2013 Oct; ():. PubMed ID: 24124110
[TBL] [Abstract][Full Text] [Related]
33. Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Murru R; Galitzia A; Barabino L; Presicci R; La Nasa G; Caocci G
Ann Hematol; 2024 May; 103(5):1655-1664. PubMed ID: 38236391
[TBL] [Abstract][Full Text] [Related]
34. Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks.
Rendeiro AF; Schmidl C; Strefford JC; Walewska R; Davis Z; Farlik M; Oscier D; Bock C
Nat Commun; 2016 Jun; 7():11938. PubMed ID: 27346425
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.
Sánchez Suárez MDM; Martín Roldán A; Alarcón-Payer C; Rodríguez-Gil MÁ; Poquet-Jornet JE; Puerta Puerta JM; Jiménez Morales A
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258066
[TBL] [Abstract][Full Text] [Related]
36. Genotyping and Copy Number Analysis of Immunoglobin Heavy Chain Variable Genes Using Long Reads.
Ford M; Haghshenas E; Watson CT; Sahinalp SC
iScience; 2020 Mar; 23(3):100883. PubMed ID: 32109676
[TBL] [Abstract][Full Text] [Related]
37. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Ahn IE; Underbayev C; Albitar A; Herman SE; Tian X; Maric I; Arthur DC; Wake L; Pittaluga S; Yuan CM; Stetler-Stevenson M; Soto S; Valdez J; Nierman P; Lotter J; Xi L; Raffeld M; Farooqui M; Albitar M; Wiestner A
Blood; 2017 Mar; 129(11):1469-1479. PubMed ID: 28049639
[TBL] [Abstract][Full Text] [Related]
38. IGHV mutational status testing in chronic lymphocytic leukemia.
Crombie J; Davids MS
Am J Hematol; 2017 Dec; 92(12):1393-1397. PubMed ID: 28589701
[TBL] [Abstract][Full Text] [Related]
39. Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Coutré SE; Furman RR; Flinn IW; Burger JA; Blum K; Sharman J; Jones J; Wierda W; Zhao W; Heerema NA; Johnson AJ; Tran A; Zhou C; Bilotti E; James DF; Byrd JC; O'Brien S
Clin Cancer Res; 2017 Mar; 23(5):1149-1155. PubMed ID: 28073846
[No Abstract] [Full Text] [Related]
40. PI3K signaling pathway in normal B cells and indolent B-cell malignancies.
Pongas G; Cheson BD
Semin Oncol; 2016 Dec; 43(6):647-654. PubMed ID: 28061982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
